Brooke Scott, MS, OTR/L | |
1350 Alum Creek Dr, Columbus, OH 43209-2705 | |
(614) 262-7520 | |
Not Available |
Full Name | Brooke Scott |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 1350 Alum Creek Dr, Columbus, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053063404 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 010680 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brooke Scott, MS, OTR/L 2211 Dublin Rd Unit 125, Columbus, OH 43228-2085 Ph: () - | Brooke Scott, MS, OTR/L 1350 Alum Creek Dr, Columbus, OH 43209-2705 Ph: (614) 262-7520 |
News Archive
In the U.S. Department of State's DipNote blog, David Lane, U.S. ambassador to the U.N. food and agriculture agencies in Rome, writes about hosting a media tour for journalists, to provide them "an opportunity to see how countries like Tanzania and Malawi are investing in agriculture and in programs to fight hunger and improve nutrition, and how development partners like the United Nations and United States are helping them.
Pennsylvania Bio today issued a new report on cancer that details the research happening through Pennsylvania companies to develop new products to diagnose and treat cancer.
In an early step toward letting severely paralyzed people speak with their thoughts, University of Utah researchers translated brain signals into words using two grids of 16 microelectrodes implanted beneath the skull but atop the brain. "We have been able to decode spoken words using only signals from the brain with a device that has promise for long-term use in paralyzed patients who cannot now speak," says Bradley Greger, an assistant professor of bioengineering.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
ViroPharma Incorporated today announced that the European Medicines Agency (EMA) has accepted the filing of its Marketing Authorization Application for Cinryze for acute treatment and prophylaxis against hereditary angioedema, which was submitted through the centralized procedure in March 2010. ViroPharma is seeking European approval for both prevention and treatment of acute attacks of hereditary angioedema.
› Verified 7 days ago
Dana Kristine Greenwell, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 Jasonway Ave, Columbus, OH 43214 Phone: 614-459-7050 | |
Molly Fichter, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2540 Billingsley Rd, Columbus, OH 43235 Phone: 614-470-2018 | |
Brian Philip Harrington, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 270 E State St, Columbus, OH 43215 Phone: 614-365-5229 | |
Kadia Leah Simon, OTD, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9180 Antares Ave, Columbus, OH 43240 Phone: 833-231-2589 | |
Jamie Ann Coburn Van Horn, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1550 Old Henderson Rd Ste S-204, Columbus, OH 43220 Phone: 614-824-2633 Fax: 614-467-3841 | |
Mr. Jonathan L Chennault, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1397 Broadview Ave, Apt 2, Columbus, OH 43212 Phone: 614-512-9879 | |
Jesse Ann Miller, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1210 Gemini Pl Ste 200, Columbus, OH 43240 Phone: 614-262-6110 |